Medicine Details
Brand name – Revolade
Generic name – Eltrombopag
Manufacturer – GSK
Salt composition – Eltrombopag 50mg
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Strength – 50mg
Packaging – Strip
Gender – Unisex
Prescription required – Yes
Indication – Used to treat chronic Hepatitis C Virus infection and severe Aplastic Anemia
Description
Revolade (Eltrombopag) 50mg tablet is used to treat chronic (long-lasting) Hepatitis C Virus (HCV) infection and severe Aplastic Anemia. It stimulates the formation of platelets in the body. Take this medicine only if you do not have any known allergy to its ingredient(s).
Pharmacodynamics
Eltrombopag is a small-molecule TPO-receptor agonist. It interacts with the transmembrane domain of the human TPO-receptor. It is a stimulator of STAT and JAK phosphorylation. Eltrombopag does not activate the AKT pathway in any way. It is clear that when given to patients with Aplastic Anemia, other lineages besides platelet count were increased.
Ingredients
The active ingredient of Revolade tablet is Eltrombopag (50mg).
Usage Of Medicine
Revolade 50mg tablet is used in the treatment of chronic Hepatitis C Virus (HCV) infection and severe Aplastic Anemia.


